Planned withdrawal of dexamethasone after pomalidomide low dose dexamethasone induction for lenalidomide refractory multiple myeloma (ALLG MM14).,Haematologica

当前位置： X-MOL 学术 › Haematologica › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Planned withdrawal of dexamethasone after pomalidomide low dose dexamethasone induction for lenalidomide refractory multiple myeloma (ALLG MM14).
Haematologica ( IF 8.2 ) Pub Date : 2021-09-30 , DOI: 10.3324/haematol.2021.278655
Anna Kalff ₁ , Tiffany Khong ₂ , Malarmathy Ramachandran ₂ , P Joy Ho ₃ , Peter Mollee ₄ , James D'Rozario ₅ , Kerry Taylor ₆ , Jane Estell ₇ , Sam Norton ₈ , Roslyn Kemp ₉ , Andrew J Mitchell ₁₀ , John Reynolds ₁₁ , Nola Kennedy ₁₂ , Hang Quach ₁₃ , Andrew Spencer ₁

Affiliation

Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria, Australia; Department of Clinical Haematology, Monash University, Clayton, Victoria.
Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria, Australia; Myeloma Research Group, Australian Centre for Blood Diseases, Alfred Hospital-Monash University, Melbourne, Victoria.
Royal Prince Alfred Hospital, Sydney.
Princess Alexandra Hospital and University of Queensland, Brisbane.
The Canberra Hospital, Canberra.
Icon Cancer Centre, Brisbane.
Concord Repatriation General Hospital, University of Sydney, Sydney.
Nanix Ltd., Dunedin, New Zealand; Department of Microbiology and Immunology, University of Otago.
Department of Microbiology and Immunology, University of Otago.
Materials Characterisation and Fabrication Platform, Department of Chemical Engineering, University of Melbourne.
Department of Epidemiology and Preventive Medicine, Alfred Health - Monash University, Melbourne, Victoria.
Malignant Haematology and Stem Cell Transplantation, Alfred Hospital, Melbourne, Victoria.
Faculty of Medicine, University of Melbourne, St Vincent's Hospital Melbourne, Australia [on behalf of The Australasian Leukaemia and Lymphoma Group (ALLG)].